Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
AssigneeApellis Pharmaceuticals, Inc.
InventorsCedric Francois, Pascal Deschatelets
Life of this patent
Estimating the term…
Loading patent…
AssigneeApellis Pharmaceuticals, Inc.
InventorsCedric Francois, Pascal Deschatelets
Estimating the term…
In some aspects, the present invention provides cell-reactive compstatin analogs and compositions comprising cell-reactive compstatin analogs. In some aspects, the invention further provides methods of using cell-reactive compstatin analogs, e.g., treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides long-acting compstatin analogs and compositions comprising long-acting compstatin analogs. In some aspects, the invention further provides methods of using long-acting compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ. In some aspects, the invention provides targeted compstatin analogs and compositions comprising targeted compstatin analogs. In some aspects, the invention further provides methods of using targeted compstatin analogs, e.g., to treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ
1-177. (canceled)
A compound of formula (XVIIa):
A compound of formula (XIXa):
A compound of formula:
A compound of formula (XIX):
Dependencies are inferred from the claim text.